{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"myalgia-eosinophilia-syndrome-associated-with-tryptophan","columns":[{"gene":"","key":"population-456f50ed801a06f281f7","label":"Myalgia-eosinophilia syndrome associated with tryptophan","mondoId":"MONDO:0016822","onsetQualifier":null,"originColumnKey":"MONDO:0016822/ORPHA:2582","originalViews":[{"key":"MONDO:0016822/ORPHA:2582","label":"Myalgia-eosinophilia syndrome associated with tryptophan","scopeLabel":"ORPHA:2582","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["2ff873f01f914e38646579d03ea4467b222d7ba893eb11352bffad9efc821c10","3829d07286cafe9dd563f23c9543f614ac514a49619ffa2b336c232d3ed7525b","40767f1ca56c44a4092c7d4cf7246e83bab9387632ad6b5bff0f6b704e619ca6","5afedfa2d915a535610d5d2db73d7a51f3db83137390890cd8f0bdf03147113c","79f729ee29124266436291cd86229091fcad646267b767fb8900373aa7775d02","95d076620cc20bc54e2123a00740144ce8099e1384bdfff6518874b9b66f1be9","9cdf557383d7b372297ecd6356d049c566869120531d3d736852b469cbe3e378","b42a3f98a1f6c8a3c33a37ab4b9589a9091205e3268f718e51c629252bf009d3","e970691af0b0fe75b430fe016511a96f3ef9456ae9cc0eb4b23c12ed6616cbe3","f3129b2a566d77aa344e2433e5960e1f31bbf53118d6d553a4a430cef9cd4fa0"],"recordQualifiers":{},"scopeLabel":"ORPHA:2582","sourceIds":["ORPHA:2582"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-456f50ed801a06f281f7"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002103","HP:0003011","HP:0001369","HP:0001888","HP:0005469","HP:0007328","HP:0001880"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":10,"sourceGroups":{"orphanet":10}},"features":[{"hpoId":"HP:0002103","label":"Abnormal pleura morphology","primary":true},{"hpoId":"HP:0003011","label":"Abnormality of the musculature","primary":true},{"hpoId":"HP:0001369","label":"Arthritis","primary":true},{"hpoId":"HP:0001888","label":"Decreased total lymphocyte count","primary":true},{"hpoId":"HP:0005469","label":"Flat occiput","primary":true},{"hpoId":"HP:0007328","label":"Impaired pain sensation","primary":true},{"hpoId":"HP:0001880","label":"Increased total eosinophil count","primary":true},{"hpoId":"HP:0001376","label":"Limitation of joint mobility","primary":false},{"hpoId":"HP:0001072","label":"Thickened skin","primary":false},{"hpoId":"HP:0001025","label":"Urticaria","primary":false}],"ledeHtml":"A rare systemic disease characterized by severe myalgia and peripheral eosinophilia associated with tryptophan dietary supplementation. The symptoms do not subside after tryptophan discontinuation. Clinical presentation includes muscle tenderness and cramps, fatigue, weakness, paresthesia, peripheral edema, arthralgia, dyspnea, skin rash, dry mouth, and development of scleroderma-like skin abnormalities.","mondoId":"MONDO:0016822","node":{"canonicalSlug":"myalgia-eosinophilia-syndrome-associated-with-tryptophan","comparisons":[{"documentSha256":"17f9e5bc173eb1aa9f9dac7c3268ed5de24488fb26703779947c820d735e1b68","key":"legacy-myalgia-eosinophilia-syndrome-associated-with-tryptophan","kind":"legacy","label":"myalgia-eosinophilia syndrome associated with tryptophan","memberIds":["MONDO:0016822"],"mondoId":"MONDO:0016822","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/myalgia-eosinophilia-syndrome-associated-with-tryptophan.17f9e5bc173eb1aa9f9dac7c3268ed5de24488fb26703779947c820d735e1b68.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"myalgia-eosinophilia syndrome associated with tryptophan","paragraphs":["A rare systemic disease characterized by severe myalgia and peripheral eosinophilia associated with tryptophan dietary supplementation. The symptoms do not subside after tryptophan discontinuation. Clinical presentation includes muscle tenderness and cramps, fatigue, weakness, paresthesia, peripheral edema, arthralgia, dyspnea, skin rash, dry mouth, and development of scleroderma-like skin abnormalities."],"scope":"exact","source":"MONDO","upstream":"Orphanet:2582","url":"https://monarchinitiative.org/MONDO:0016822"},"ownColumnKeys":["population-456f50ed801a06f281f7"],"publication":"published","relationships":[{"kind":"parent","label":"rheumatic disorder","mondoId":"MONDO:0005554","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/18775"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"2ff873f01f914e38646579d03ea4467b222d7ba893eb11352bffad9efc821c10","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2582","disease_name":"Myalgia-eosinophilia syndrome associated with tryptophan","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001369","is_excluded":false,"label":"Arthritis","onset_id":null,"reference":"ORPHA:2582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3829d07286cafe9dd563f23c9543f614ac514a49619ffa2b336c232d3ed7525b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2582","disease_name":"Myalgia-eosinophilia syndrome associated with tryptophan","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003011","is_excluded":false,"label":"Abnormality of the musculature","onset_id":null,"reference":"ORPHA:2582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"40767f1ca56c44a4092c7d4cf7246e83bab9387632ad6b5bff0f6b704e619ca6","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:2582","disease_name":"Myalgia-eosinophilia syndrome associated with tryptophan","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0005469","is_excluded":false,"label":"Flat occiput","onset_id":null,"reference":"ORPHA:2582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5afedfa2d915a535610d5d2db73d7a51f3db83137390890cd8f0bdf03147113c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:2582","disease_name":"Myalgia-eosinophilia syndrome associated with tryptophan","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007328","is_excluded":false,"label":"Impaired pain sensation","onset_id":null,"reference":"ORPHA:2582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"79f729ee29124266436291cd86229091fcad646267b767fb8900373aa7775d02","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:2582","disease_name":"Myalgia-eosinophilia syndrome associated with tryptophan","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002103","is_excluded":false,"label":"Abnormal pleura morphology","onset_id":null,"reference":"ORPHA:2582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"95d076620cc20bc54e2123a00740144ce8099e1384bdfff6518874b9b66f1be9","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2582","disease_name":"Myalgia-eosinophilia syndrome associated with tryptophan","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001072","is_excluded":false,"label":"Thickened skin","onset_id":null,"reference":"ORPHA:2582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9cdf557383d7b372297ecd6356d049c566869120531d3d736852b469cbe3e378","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2582","disease_name":"Myalgia-eosinophilia syndrome associated with tryptophan","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001376","is_excluded":false,"label":"Limitation of joint mobility","onset_id":null,"reference":"ORPHA:2582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b42a3f98a1f6c8a3c33a37ab4b9589a9091205e3268f718e51c629252bf009d3","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:2582","disease_name":"Myalgia-eosinophilia syndrome associated with tryptophan","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001888","is_excluded":false,"label":"Decreased total lymphocyte count","onset_id":null,"reference":"ORPHA:2582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e970691af0b0fe75b430fe016511a96f3ef9456ae9cc0eb4b23c12ed6616cbe3","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:2582","disease_name":"Myalgia-eosinophilia syndrome associated with tryptophan","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001025","is_excluded":false,"label":"Urticaria","onset_id":null,"reference":"ORPHA:2582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f3129b2a566d77aa344e2433e5960e1f31bbf53118d6d553a4a430cef9cd4fa0","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:2582","disease_name":"Myalgia-eosinophilia syndrome associated with tryptophan","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001880","is_excluded":false,"label":"Increased total eosinophil count","onset_id":null,"reference":"ORPHA:2582","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016822\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:2582</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare systemic disease characterized by severe myalgia and peripheral eosinophilia associated with tryptophan dietary supplementation. The symptoms do not subside after tryptophan discontinuation. Clinical presentation includes muscle tenderness and cramps, fatigue, weakness, paresthesia, peripheral edema, arthralgia, dyspnea, skin rash, dry mouth, and development of scleroderma-like skin abnormalities.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016822\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"myalgia-eosinophilia-syndrome-associated-with-tryptophan","sourceDocuments":[{"name":"MONDO: myalgia-eosinophilia syndrome associated with tryptophan","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0016822"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"myalgia-eosinophilia syndrome associated with tryptophan"},"schemaVersion":1}
